908devices. Jun 4, 2023 · Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ...908 Devices Inc manufactures medical devices. It has developed an innovative suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. We are headquartered in the heart of Boston, where we research, design and manufacture innovative products that bring together the power of mass spectrometry, …Jun 4, 2023 · Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More BOSTON, August 09, 2022 -- ( BUSINESS WIRE )-- 908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today...908 Devices had revenue of $9.49M in the quarter ending March 31, 2023 with 14.22% year-over-year growth. This brings the trailing twelve month (ttm) revenue to $48.03M, up 6.81% year-over-year. In the year 2022, 908 Devices had annual revenue of $46.85M with 11.01% growth. Revenue (ttm)908 Devices had revenue of $9.49M in the quarter ending March 31, 2023 with 14.22% year-over-year growth. This brings the trailing twelve month (ttm) revenue to $48.03M, up 6.81% year-over-year. In the year 2022, 908 Devices had annual revenue of $46.85M with 11.01% growth.Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More908 Devices had revenue of $9.49M in the quarter ending March 31, 2023 with 14.22% year-over-year growth. This brings the trailing twelve month (ttm) revenue to $48.03M, up 6.81% year-over-year. In the year 2022, 908 Devices had annual revenue of $46.85M with 11.01% growth. Revenue (ttm)Stephens has initiated coverage on 908 Devices Inc (NASDAQ: MASS) with an Overweight rating and a price target of $14. The analyst notes the company has healthy gross margins in the mid-50%s, with ...May 9, 2023 · 908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -11.43%. Stephens has initiated coverage on 908 Devices Inc (NASDAQ: MASS) with an Overweight rating and a price target of $14. The analyst notes the company has healthy gross margins in the mid-50%s, with ...Jun 4, 2023 · Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More BCTNP ... bctnp 908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -11.43…Bringing the powerful capabilities of #MassSpectrometry out of the confines of centralized laboratories for analysis wherever and whenever it is needed2 days ago · $48.03M Revenue Growth +6.81% P/S Ratio 6.11 Revenue / Employee $211,599 Employees 227 Market Cap 293.63M Revenue Chart 908 Devices Revenue - Annual 2019 2020 2021 2022 2023 - 10M 20M 30M 40M 5Y 10Y Max Revenue History Annual Export We are revolutionizing chemical and biochemical analysis with our simple handheld and desktop devices for critical-to-life applications.908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ...908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ...Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More908 Devices had revenue of $9.49M in the quarter ending March 31, 2023 with 14.22% year-over-year growth. This brings the trailing twelve month (ttm) revenue to $48.03M, up 6.81% year-over-year. In the year 2022, 908 Devices had annual revenue of $46.85M with 11.01% growth.908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ... oil companies in tulsadugan truck linesstella and dot 2 days ago · $48.03M Revenue Growth +6.81% P/S Ratio 6.11 Revenue / Employee $211,599 Employees 227 Market Cap 293.63M Revenue Chart 908 Devices Revenue - Annual 2019 2020 2021 2022 2023 - 10M 20M 30M 40M 5Y 10Y Max Revenue History Annual Export 908 Devices is revolutionizing chemical and biochemical analysis with its mass spec devices that are simple to operate, provide answers in minutes and are used at the point of need. The company's ... May 30, 2023 · 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ... inpirato 908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00. mawer Jun 4, 2023 · Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More 908 Devices is revolutionizing chemical and biochemical analysis with its mass spec devices that are simple to operate, provide answers in minutes and are used at the point of need. The company's ... Jun 4, 2023 · Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More rippl care908 Devices Inc manufactures medical devices. It has developed an innovative suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. web motors About About See all 645 Summer St Boston, MA 02210 We make point-of-need-devices ranging from rugged, handheld chemical detection tools to compact, tiny footprint analyzers and fast separation devices. 2 days ago · $48.03M Revenue Growth +6.81% P/S Ratio 6.11 Revenue / Employee $211,599 Employees 227 Market Cap 293.63M Revenue Chart 908 Devices Revenue - Annual 2019 2020 2021 2022 2023 - 10M 20M 30M 40M 5Y 10Y Max Revenue History Annual Export 2 days ago · 908 Devices had revenue of $9.49M in the quarter ending March 31, 2023 with 14.22% year-over-year growth. This brings the trailing twelve month (ttm) revenue to $48.03M, up 6.81% year-over-year. In the year 2022, 908 Devices had annual revenue of $46.85M with 11.01% growth. 908 Devices, is democratizing chemical analysis by way of mass spectrometry, offering point-of-need chemical analysis devices ranging from rugged, handheld chemical detection tools to compact, tiny footprint analyzers and fast separation devices.908 Devices is a company offering handheld and desktop mass spec devices for chemical and biomolecular analysis. It offers a range of products, including rugged, handheld chemical detection tools, compact footprint analyzers, and fast separation devices. tubro 908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -11.43…Jun 6, 2023 · 908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00. 908 Devices is revolutionizing chemical and biochemical analysis with its mass spec devices that are simple to operate, provide answers in minutes and are used at the point of need. The company's ... 908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00. conam Feb 7, 2012 · 908 Devices @908Devices Bringing the powerful capabilities of #MassSpectrometryout of the confines of centralized laboratories for analysis wherever and whenever it is needed Science & TechnologyBoston, MA908devices.comJoined February 2012 382Following 960Followers Tweets Replies Media Likes 908 Devices’s Tweets 908 Devices @908Devices 13h BCTNP ... bctnp “Mass spectrometry is a powerful chemical measurement tool which can provide a lot of molecular specificity – right down to the exact molecule you’re detecting,” says Mike Ramsey, 908 Devices scientific founder and Minnie N. Goldby Distinguished Professor of Chemistry. mimik Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read MoreNov 14, 2022 · BOSTON–(BUSINESS WIRE)–. 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results for the quarter ended September 30, 2022. “We were pleased with our results for the third quarter as we continue to support our customers ... High Pressure Mass Spectrometry | Technology | 908 Devices Technology Analysis For Life Our point-of-need handheld and desktop devices … north american distribution Jun 4, 2023 · Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ...Jun 6, 2023 · BOSTON-- (BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the upcoming William B... 1 week ago - Business Wire 908 Devices Reports First Quarter 2023 Financial Results and Reiterates 2023 Revenue Outlook drivewealth Jun 4, 2023 · Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More Emerging synthetic drugs make it challenging for law enforcement to keep up. MX908 delivers exceptional selectivity and sensitivity for identification of priority drugs. This handheld tool leverages high-pressure mass …For the Masses. Our microscale mass spectrometry devices pack high-performance MS into low-cost and easy to operate handheld and desktop devices that are ready to go at …908 Devices is revolutionizing chemical and biochemical analysis with its mass spec devices that are simple to operate, provide answers in minutes and are used at the point of need. The company's ... erb and henry equipment inc Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read MoreBOSTON, May 04, 2023 -- ( BUSINESS WIRE )-- 908 Devices Inc ., (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announced the release...The ZipChip® system is a microfluidic device that integrates capillary electrophoresis (CE) with electrospray ionization. The system employs zone electrophoresis, where analytes are injected as a small band and are then separated in an electric field. comlinkdata 908 Devices is revolutionizing chemical and biochemical analysis with its mass spec devices that are simple to operate, provide answers in minutes and are used at the point of need. The company's ... BOSTON, May 30, 2023--908 Devices Inc (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, is showcasing its ZipChip CE-MS device for... May 9, 2023 · 908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -11.43%. puthaven farms Molly Levenberg Executive Assistant at 908devices Boston, Massachusetts, United States 806 followers 500+ connections Join to view profile 908 Devices Northeastern University About...Jun 6, 2023 · 908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00. Jun 6, 2023 · 908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00. mymo Jun 6, 2023 · 908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00. 908 Devices had revenue of $9.49M in the quarter ending March 31, 2023 with 14.22% year-over-year growth. This brings the trailing twelve month (ttm) revenue to $48.03M, up 6.81% year-over-year. In the year 2022, 908 Devices had annual revenue of $46.85M with 11.01% growth.May 30, 2023 · 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ... heritage hauling inc About MASS. 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets.Revenue of $11.6 million for the fourth quarter 2022, compared to $15.8 million in the fourth quarter 2021, which included an $8 million shipment of MX908 devices to … pequea boat club If you're a small business in need of assistance, please contact [email protected]
May 30, 2023 · 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ... Jun 4, 2023 · Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More vatera Jun 6, 2023 · 908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00. Apr 2, 2019 · With roots at the University of North Carolina at Chapel Hill, 908 Devices is a pioneer of purpose-built analytical devices for chemical and biomolecular analysis. Over the past few years, 908 Devices has quietly advanced from a startup to a nearly 100-employee company – making an impact through its work in chemical and biomolecular analysis. Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read MoreAug 9, 2022 · BOSTON, August 09, 2022 -- ( BUSINESS WIRE )-- 908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today... ecarzi Our microscale mass spectrometry devices pack high-performance MS into low-cost and easy to operate handheld and desktop devices that are ready to go at the point of need. 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The …908 Devices had revenue of $9.49M in the quarter ending March 31, 2023 with 14.22% year-over-year growth. This brings the trailing twelve month (ttm) revenue to $48.03M, up 6.81% year-over-year. In the year 2022, 908 Devices had annual revenue of $46.85M with 11.01% growth. Revenue (ttm) powercraft marine Jun 4, 2023 · Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More 908 Devices is revolutionizing chemical and biochemical analysis with its mass spec devices that are simple to operate, provide answers in minutes and are used at the point of need. The company's ... pkz 908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00.May 30, 2023 · 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ... slync 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ...Q3 2022 revenue increases 26% over prior year, with gross margin of 59%. BOSTON–(BUSINESS WIRE)–. 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose …May 9, 2023 · 908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -11.43%. itgoJun 4, 2023 · Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More 908 Devices Aug 2021 - Present1 year 11 months Research Triangle Park, North Carolina Adjunct Assistant Professor Duke University School of …908 Devices Inc manufactures medical devices. It has developed an innovative suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. simfoni May 9, 2023 · 908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -11.43%. 908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, continues to equip … cactus software May 30, 2023 · 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ... 908 Devices is a company offering handheld and desktop mass spec devices for chemical and biomolecular analysis. It offers a range of products, including rugged, handheld chemical detection tools, compact footprint analyzers, and fast separation devices.Our microscale mass spectrometry devices pack high-performance MS into low-cost and easy to operate handheld and desktop devices that are ready to go at the point of need. BOSTON, August 09, 2022 -- ( BUSINESS WIRE )-- 908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announces ...908 Devices @908Devices 13h MX908 users can conduct field analysis of unknown substances at trace levels to assess threat levels, establish probable cause and prioritize investigatory resources … company update 2 days ago · $48.03M Revenue Growth +6.81% P/S Ratio 6.11 Revenue / Employee $211,599 Employees 227 Market Cap 293.63M Revenue Chart 908 Devices Revenue - Annual 2019 2020 2021 2022 2023 - 10M 20M 30M 40M 5Y 10Y Max Revenue History Annual Export 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ...908 Devices had revenue of $9.49M in the quarter ending March 31, 2023 with 14.22% year-over-year growth. This brings the trailing twelve month (ttm) revenue to $48.03M, up 6.81% year-over-year. In the year 2022, 908 Devices had annual revenue of $46.85M with 11.01% growth. Revenue (ttm) behaviorist on call May 9, 2023 · 908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -11.43%. 908 Devices is revolutionizing chemical and biochemical analysis with its mass spec devices that are simple to operate, provide answers in minutes and are used at the point of need. The company's ... BCTNP ... bctnp emerald x Jun 6, 2023 · 908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00. Found 14 of over 14 reviews Sort Popular Popular Most Recent Highest Rating zanacorp 908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, …May 9, 2023 · 908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -11.43%. Jun 4, 2023 · Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More Jun 6, 2023 · 908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00. Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More sunteck transport co llc 908 Devices is revolutionizing chemical and biochemical analysis with its mass spec devices that are simple to operate, provide answers in minutes and are used at the point of need. The company's ... Feb 7, 2012 · 908 Devices @908Devices Bringing the powerful capabilities of #MassSpectrometryout of the confines of centralized laboratories for analysis wherever and whenever it is needed Science & TechnologyBoston, MA908devices.comJoined February 2012 382Following 960Followers Tweets Replies Media Likes 908 Devices’s Tweets 908 Devices @908Devices 13h Bringing the powerful capabilities of #MassSpectrometry out of the confines of centralized laboratories for analysis wherever and whenever it is needed kingpoint 5 free lookups per month. No credit card required. Location Boston, MA, US Work VP, Production and NPI @ 908 Devices Director of Component Engineering @ 908 Devices VP Engineering @ TeraDiode, Inc. see more Education University of Strathclyde Doctor of Philosophy (Ph.D.) (Optoelectronics) 1983 - 1987 Skills Engineering Management Fiber …Jun 4, 2023 · Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More 908 Devices, is democratizing chemical analysis by way of mass spectrometry, offering point-of-need chemical analysis devices ranging from rugged, handheld chemical detection tools to compact, tiny footprint analyzers and fast separation devices.Aug 9, 2022 · BOSTON, August 09, 2022 -- ( BUSINESS WIRE )-- 908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today... Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read MoreOur microscale mass spectrometry devices pack high-performance MS into low-cost and easy to operate handheld and desktop devices that are ready to go at the point of need. biobot analytics 908 Devices @908Devices 13h MX908 users can conduct field analysis of unknown substances at trace levels to assess threat levels, establish probable cause and prioritize investigatory resources …Mar 31, 2021 · 908 Devices Inc. - 908 Devices Reports First Quarter 2022 Financial Results and Reiterates 2022 Revenue Outlook Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read MoreStephens has initiated coverage on 908 Devices Inc (NASDAQ: MASS) with an Overweight rating and a price target of $14. The analyst notes the company has healthy gross margins in the mid-50%s, with ... cerebral news Find it. Even at trace levels. MX908 detects compounds at trace levels with a high level of sensitivity and unparalleled selectivity, giving you actionable intelligence that other …Jun 6, 2023 · 908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00. [email protected] | 908Devices.com PTIONS Report format: CSV and PDF Betaine Alanyl-glutamine Aspartic acid Glutamic acid Histidine Lysine Proline ryptophan. triple h transport May 9, 2023 · 908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -11.43%. 2 days ago · 908 Devices had revenue of $9.49M in the quarter ending March 31, 2023 with 14.22% year-over-year growth. This brings the trailing twelve month (ttm) revenue to $48.03M, up 6.81% year-over-year. In the year 2022, 908 Devices had annual revenue of $46.85M with 11.01% growth. accurate assessor 908 Devices had revenue of $9.49M in the quarter ending March 31, 2023 with 14.22% year-over-year growth. This brings the trailing twelve month (ttm) revenue to $48.03M, up 6.81% year-over-year. In the year 2022, 908 Devices had annual revenue of $46.85M with 11.01% growth. Revenue (ttm)Collaboration: 908 Devices, Weizmann Institute of Science: MP 548: Combining Capillary Electrophoresis and Trapped Ion Mobility Spectrometry Mass Spectrometry to Analyze … action gypsum supply Combining award winning design with 908 Devices proven capillary electrophoresis and high-pressure mass spectrometry technologies, the REBEL provides process development scientists access to critical data at-line, any time. ANALYSIS IN 4 EASY STEPS PULL A SAMPLE Pull a sample from your bioreactor, shake flask, or well plate.Q3 2022 revenue increases 26% over prior year, with gross margin of 59% BOSTON–(BUSINESS WIRE)– 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results for the quarter ended September 30, 2022. “We were pleased with our results for the third quarter as we continue to ...Bringing the powerful capabilities of #MassSpectrometry out of the confines of centralized laboratories for analysis wherever and whenever it is needed xp health
Solutions from 908devices, Inc. Yellow Pages directories can mean big success stories for your. 908devices White Pages are public records which are documents or pieces of information that are not considered confidential and can be viewed instantly online. me/908devices If you're a small business in need of assistance, please contact [email protected]